Home › Stocks › AMPH › All Fund Holders
AMPH — AMPHASTAR PHARMACEUTICALS IN · All Fund Holders
Funds holding (latest): 40 · Reported value held: $226.06M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 2.61M | $69.85M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 1.07M | $21.52M | 0.02% | Add |
| Geode Capital Management history | Q2 2026 | 969.84K | $19.58M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 887.05K | $17.90M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 525.10K | $10.60M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 505.36K | $10.20M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 393.11K | $7.93M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 370.99K | $7.49M | 0.00% | Hold |
| Charles Schwab Investment Management history | Q2 2026 | 310.18K | $6.26M | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 6.83M | $6.19M | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 294.76K | $5.95M | 0.05% | Reduce |
| Two Sigma Investments history | Q2 2026 | 248.12K | $5.01M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 532.34K | $4.96M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 208.65K | $4.21M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 204.25K | $4.12M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 158.06K | $3.19M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 136.82K | $2.76M | 0.00% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 116.65K | $2.35M | 0.00% | Reduce |
| PSP Investments history | Q2 2026 | 116.65K | $2.35M | 0.01% | Reduce |
| Balyasny Asset Management history | Q4 2025 | 77.47K | $2.07M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 78.28K | $1.58M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 57.56K | $1.19M | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 55.78K | $1.13M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 54.96K | $1.11M | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 890.00K | $807.67K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 37.63K | $759.39K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 35.31K | $712.50K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 35.13K | $708.98K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 31.81K | $642.01K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 28.96K | $584.36K | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 24.99K | $504.22K | 0.00% | Reduce |
| Wellington Management Group history | Q3 2025 | 17.20K | $458.35K | 0.00% | Add |
| Amundi US history | Q1 2025 | 14.93K | $406.56K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 16.87K | $330.70K | 0.00% | Hold |
| Manulife Financial history | Q2 2026 | 14.25K | $287.50K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 11.50K | $232.07K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 5.00K | $100.98K | 0.00% | Reduce |
| Lazard Asset Management history | Q4 2025 | 2.47M | $22.92K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 4.00K | $3.63K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 51.10K | $1.03K | 0.00% | Add |